Skip to main content
. 2007 May 16;110(7):2620–2630. doi: 10.1182/blood-2006-11-059139

Table 2.

Evaluation of CD30 expression on T cells during the generation of EBV-CTLs and on CD30CAR+ EBV-CTLs

Stimulation
First Second Third Fourth or more
CD3+ T cells/EBV-CTLs 14 ± 8 5 ± 4 6 ± 6 3 ± 5
CD30CAR+ EBV-CTLs 3.7 ± 1.8 7.2 ± 5.5 7.3 ± 4.5 1.8 ± 0.4

Data are percentages of T cells. Evaluation of CD30 expression on CD3+ T cells/CTLs and on CD30CAR+ CTLs 5 to 7 days after the indicated stimulation with autologous LCLs. Analysis was performed by FACS after staining with CD30 PE-labeled MAb. CD30 expression on circulating T cells is less than 1%.